Tenofovir alafenamide hemifumarate

본문 바로가기


Home > Product > Tenofovir alafenamide hemifumarate
Selling leads
Tenofovir alafenamide hemifumarate
Posting date : Jun 30, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Vemlidy (Tenofovir alafolamine fumarate, 25mg, once daily) has been approved by the US FDA for the treatment of chronic hepatitis B virus infection in compensatory liver disease. Vemlidy is an innovation of targeting drug tenofovir ago, with previous products 300 mg of Viread (tenofovir ester fumaric acid salt, tenofovirdisChemicalbookoproxilfumarate), compared to only need less than one over ten of the dose can obtain similar antiviral activity. Clinical data show that Vemlidy has better plasma stability and can deliver tenofovir to hepatocytes more effectively. Due to a lower dosage, Vemlidy can improve the safety risks of patients' kidneys and bones.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top